ERBB2 and breast cancer: Furthermore, the existing literature corroborates the significant predictive capacity of the CPS+EG score for both overall survival (OS) and distant metastasis-free survival (DMFS) across different breast cancer subtypes, including HER2-positive and triple-negative breast cancer (TNBC) [18].